Kyowa Kirin Inc.- U.S. Revenue and Competitors
Estimated Revenue & Valuation
- Kyowa Kirin Inc.- U.S.'s estimated annual revenue is currently $145.5M per year.
- Kyowa Kirin Inc.- U.S.'s estimated revenue per employee is $201,000
Employee Data
- Kyowa Kirin Inc.- U.S. has 724 Employees.
- Kyowa Kirin Inc.- U.S. grew their employee count by 30% last year.
Kyowa Kirin Inc.- U.S.'s People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP, N. America Quality Assurance | Reveal Email/Phone |
2 | VP, Global Head Clinical Pharmacology | Reveal Email/Phone |
3 | VP Market Access and Pricing | Reveal Email/Phone |
4 | VP, Global Product Lead Istradefylline, Global Product Strategy Lead Rocatinlimab, CoS KKNA | Reveal Email/Phone |
5 | Associate Director, Medical Writing (Oncology) | Reveal Email/Phone |
6 | EVP, Chief Compliance Officer and General Counsel at Kyowa Kirin North America | Reveal Email/Phone |
7 | Director, Corporate Counsel | Reveal Email/Phone |
8 | Director, NA Oncology Franchise Operations | Reveal Email/Phone |
9 | Senior Director, Global Market Access Strategy, New Products | Reveal Email/Phone |
10 | Executive Director | Reveal Email/Phone |
Kyowa Kirin Inc.- U.S. Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5M | 25 | -11% | N/A | N/A |
#2 | $35.8M | 178 | 8% | N/A | N/A |
#3 | $5.4M | 27 | -25% | N/A | N/A |
#4 | $4180M | 14516 | 1% | $550M | N/A |
#5 | $12.5M | 62 | 15% | N/A | N/A |
#6 | $6.7M | 119 | -37% | $199.6M | N/A |
#7 | $9.4M | 47 | 7% | N/A | N/A |
#8 | $10.3M | 51 | 6% | N/A | N/A |
#9 | $106.3M | 529 | 16% | N/A | N/A |
#10 | $15.5M | 77 | 20% | N/A | N/A |
What Is Kyowa Kirin Inc.- U.S.?
With US headquarters in Bedminster, NJ, Kyowa Kirin is a growing specialty pharmaceutical company focused on developing and commercializing prescription medicines that help improve the health and well-being of people through innovative drug developments and state-of-the-art technologies in oncology, nephrology, and immunology. For more information, you can visit us at www.kyowa-kirin.com.
keywords:N/A
N/A
Total Funding
724
Number of Employees
$145.5M
Revenue (est)
30%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Kyowa Kirin Inc.- U.S. News
Kyowa Kirin Co. Ltd., Pfizer Inc., Astellas Pharma, Bayer AG, Elorac Dover Medical and Scientific Equipment, Ltd. This Mycosis Fungoides...
Kolon TissueGene, the license holder for TG-C in the US (not TG-C LD), ... Ardelyx Inc. and Kyowa Kirin Co., Ltd. amended their 2017...
WALTHAM, Mass., April 11, 2022 /PRNewswire/ -- Ardelyx Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover,...
10, 2019 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (RARE), ... Crysvita is approved by the U.S. FDA, Health Canada, and Brazil's National Health ... Kyowa Kirin and Ultragenyx have been collaborating in the ...
Kyowa Kirin, Inc., a global specialty pharmaceutical company, has ... and our collaboration with Dream Foundation allows us to live our values ...
Other Companies in Bedminster
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $145.5M | 724 | 30% | N/A |
#2 | $429.5M | 2360 | 58% | N/A |